Table 2 Relationship between variables affected by MCV-containing cART and the magnitude of the HBV vaccine response

% CD4⁺ RTE

78.0 [67.0–82.5]

0.599; 6.2 [− 18.0–30.3]

% CD4⁺ HLA-DR⁺

1.8 [1.0–2.0]

0.038; − 211.2 [− 409.6–12.8]

% CD4⁺ ki67⁺

2.4 [2.0–3.1]

0.027; − 241.7 [− 452.8–30.5]

% CD4⁺ CD25^hiFoxP3⁺

1.2 [0.9–2.0]

0.889; − 17.0 [− 267.7–233.78]

% mDCs

0.5 [0.3–0.8]

0.272; 196.1 [− 166.3–558.5]